Home > Level 1 > Level 2 > Level 3 > Heading 1
Heading 1

|
WEDNESDAYS, 1-2:30 P.M.
LECTURE HALL 1 (unless otherwise noted)
|
OBJECTIVE: TO KEEP PRACTITIONERS ABREAST OF THE ADVANCES IN
THE TREATMENT OF PSYCHIATRIC DISORDER |
| Mar 5 |
Endophenotypes & Susceptibility Genes For Alcohol Dependence |
|
BERNICE PORJESZ, Ph.D
Associate Professor
Department of Psychiatry
SUNY Downstate Medical Center
Brooklyn, NY
(Lecture Hall 1A, BSB)
|
|
| Mar 12 |
DUpdate On the Relationship Between Depression & Coronary Heart Disease |
|
PETER SHAPIRO, M.D.
Assoc. Professor
Clinical Psychiatry
College of Physicians & Surgeons
Columbia University
New York, NY
|
|
| Mar 19 |
The Metabolic Consequences of Atypical Anti-Psychotic Drugs
|
|
HAROLD LEBOVITZ, M.D.
Professor of Medicine
SUNY Downstate Medical Center
|
|
| Mar 26 |
Aripiprazole: New Development in Anti-Psychotic Medication
|
|
PETER WEIDEN, M.D.
Professor of Psychiatry
SUNY Downstate Medical Center
Brooklyn, NY
(See Disclosure statement)
|
|
* Off Label Drugs/Device Usage: None
* Target audience: All mental health care providers and trainees
|
|
|
The SUNY (State University of New York) Downstate Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The SUNY Downstate Medical Center designates this continuing medical education activity for a maximum of 1.5 hours of Category 1 credit toward the American Medical Association Physicians Recognition Award (AMA/PRA). Each physician should claim only those hours of credit that he/she actually spent in the educational activity.
Disclaimer Statement:
SUNY Downstate Medical Center and its affiliates are committed to providing educational activities that are objective, balanced and as free of bias as possible. All participating faculty are expected to disclose to the audience, verbally or in writing, any commercial relationships that might be perceived as a real or apparent conflict of interest related to the content of their presentations, i.e. with companies whose products or services are related to the subject matter of the presentation, or products in the research and development phase.
|
|